Abstract:Monoterpene indole alkaloids (MIAs) are a class of natural products comprised of thousands of structurally unique bioactive compounds with significant therapeutic values. Due to difficulties associated with isolation from native plant species and organic synthesis of these structurally complex molecules, microbial production of MIAs using engineered hosts are highly desired. In this work, we report the engineering of fully integrated Saccharomyces cerevisiae strains that allow de novo access to strictosidine, the universal precursor to thousands of MIAs at 30-40 mg/L. The optimization efforts were based on a previously reported yeast strain that is engineered to produce high titers of the monoterpene precursor geraniol through compartmentalization of mevalonate pathway in the mitochondria. Our approaches here included the use of CRISPR-dCas9 interference to identify mitochondria diphosphate transporters that negatively impact the titer of the monoterpene, followed by genetic inactivation; the overexpression of transcriptional regulators that increase cellular respiration and mitochondria biogenesis. Strain construction included the strategic integration of genes encoding both MIA biosynthetic and accessory enzymes into the genome under a variety of constitutive and inducible promoters. Following successful de novo production of strictosidine, complex alkaloids belonging to heteroyohimbine and corynantheine families were reconstituted in the host with introduction of additional downstream enzymes. We demonstrate that the serpentine/alstonine pair can be produced at ∼5 mg/L titer, while corynantheidine, the precursor to mitragynine can be produced at ∼1 mg/L titer. Feeding of halogenated tryptamine led to the biosynthesis of analogs of alkaloids in both families. Collectively, our yeast strain represents an excellent starting point to further engineer biosynthetic bottlenecks in this pathway and to access additional MIAs and analogs through microbial fermentation. One sentence summary: An Saccharomyces cerevisiae-based microbial platform was developed for the biosynthesis of monoterpene indole alkaloids, including the universal precursor strictosidine and further modified heteroyohimbine and corynantheidine alkaloids.

De Novo Synthesis of 1-Phenethylisoquinoline in Engineered Escherichia Coli

Metabolic Engineering of Pseudomonas Chlororaphis for De Novo Production of Iodinin from Glycerol

Elucidation of the 1-phenethylisoquinoline pathway from an endemic conifer Cephalotaxus hainanensis

Metabolic engineering for the biosynthesis of bis-indolylquinone terrequinone A in Escherichia coli from L-tryptophan and prenol

Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate l-pipecolic acid in Escherichia coli

Efficient Biosynthesis of Heterodimeric C3-aryl Pyrroloindoline Alkaloids

Engineering Escherichia Coli for High-Yielding 2,5-Dimethylpyrazine Synthesis from L-Threonine by Reconstructing Metabolic Pathways and Enhancing Cofactors Regeneration

Metabolic Engineering of Escherichia coli for Production of 2,5-Dimethylpyrazine

Mechanism-based tuning of insect 3,4-dihydroxyphenylacetaldehyde synthase for synthetic bioproduction of benzylisoquinoline alkaloids

De novo production of protoberberine and benzophenanthridine alkaloids through metabolic engineering of yeast

Biosynthesis of Plant Tetrahydroisoquinoline Alkaloids Through an Imine Reductase Route

A yeast platform for high-level synthesis of tetrahydroisoquinoline alkaloids

Establishing biosynthetic pathway for the production of p-hydroxyacetophenone and its glucoside in Escherichia coli

Metabolic Engineering of Escherichia coli for the Biosynthesis of 3-Phenylpropionic Acid and 3-Phenylpropyl Acetate

A yeast platform for high-level synthesis of natural and unnatural tetrahydroisoquinoline alkaloids

Advancements in Microbial Cell Engineering for Benzylisoquinoline Alkaloid Production

Metabolic engineering of Escherichia coli for N-methylserotonin biosynthesis

De novo Synthesis of 2-phenylethanol from Glucose by Metabolically Engineered Escherichia coli

Metabolic Engineering of Pseudomonas Chlororaphis Qlu-1 for the Enhanced Production of Phenazine-1-carboxamide.

Engineered biosynthesis of plant heteroyohimbine and corynantheine alkaloids in Saccharomyces cerevisiae

Biosynthesis and metabolic engineering of 1-hydroxyphenazine in Pseudomonas chlororaphis H18